" class="no-js "lang="en-US"> Josh Russell - Medtech Alert
Monday, December 11, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Joshua Russell | MTA

Josh Russell

About Josh Russell

Solutions driven professional passionate about developing innovative and timely technologies that address pressing challenges within the biopharma and pharmaceutical industries.

Related Story

Medtech TV

 Josh Russell, AST, on Small Patch Applications for Drug Products | MTA

Josh Russell, AST, on Small Patch Applications for Drug Products

February 15 2023

In this interview, Josh Russell from AST discusses the range of products offered by the […]

Related People

Josh Russell

Josh Russell

Related Company

AST